Most patients with rheumatoid arthritis is not satisfied with current equipment subcutaneous self-administration of medication, a study released in Rome at a meeting of European League Against Rheumatoid Arthritis.
Between 80-90 percent of the participants reported at least one negative aspect of self-administration, the study RAISE, which was developed to gain a better understanding of the concerns of these patients using these devices.
Although more than half of patients consider the devices easy to use self-injection, over a third admitted to not knowing if the treatment is administered correctly
The study said 36 percent of patients questioned indicated pain and redness at the injection site, 10 percent admit I miss a dose because of the pain. In addition, 10 percent of patients fail treatment have thought the same reason.
